BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25874628)

  • 1. A systematic model specification procedure for an illness-death model without recovery.
    Eulenburg C; Mahner S; Woelber L; Wegscheider K
    PLoS One; 2015; 10(4):e0123489. PubMed ID: 25874628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation and prediction in a multi-state model for breast cancer.
    Putter H; van der Hage J; de Bock GH; Elgalta R; van de Velde CJ
    Biom J; 2006 Jun; 48(3):366-80. PubMed ID: 16845902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint modelling of repeated transitions in follow-up data--a case study on breast cancer data.
    Genser B; Wernecke KD
    Biom J; 2005 Jun; 47(3):388-401. PubMed ID: 16053262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of routine follow-up examinations on life expectancy in ovarian cancer patients: a simulation study.
    Geurts SM; de Vegt F; van Altena AM; Tjan-Heijnen VC; Massuger LF; Adang EM; van Dijck JA; Verbeek AL
    Int J Gynecol Cancer; 2012 Sep; 22(7):1150-7. PubMed ID: 22864333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Markov and time homogeneity assumptions in multi-state models: application in patients with gastric cancer undergoing surgery in the Iran cancer institute.
    Ali Z; Mahmood M; Kazem M; Hojjat Z; Mostafa H; Kourosh HN
    Asian Pac J Cancer Prev; 2014; 15(1):441-7. PubMed ID: 24528071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. tdc.msm: an R library for the analysis of multi-state survival data.
    Meira-Machado L; Cadarso-Suárez C; de Uña-Alvarez J
    Comput Methods Programs Biomed; 2007 May; 86(2):131-40. PubMed ID: 17350136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frailties in multi-state models: Are they identifiable? Do we need them?
    Putter H; van Houwelingen HC
    Stat Methods Med Res; 2015 Dec; 24(6):675-92. PubMed ID: 22116343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric estimation of transition probabilities in the non-Markov illness-death model: A comparative study.
    de Uña-Álvarez J; Meira-Machado L
    Biometrics; 2015 Jun; 71(2):364-75. PubMed ID: 25735883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between parametric and semi-parametric cox models in modeling transition rates of a multi-state model: application in patients with gastric cancer undergoing surgery at the Iran cancer institute.
    Zare A; Mahmoodi M; Mohammad K; Zeraati H; Hosseini M; Naieni KH
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6751-5. PubMed ID: 24377600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A censored quantile regression approach for the analysis of time to event data.
    Xue X; Xie X; Strickler HD
    Stat Methods Med Res; 2018 Mar; 27(3):955-965. PubMed ID: 27166408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-state relative survival modelling of colorectal cancer progression and mortality.
    Gilard-Pioc S; Abrahamowicz M; Mahboubi A; Bouvier AM; Dejardin O; Huszti E; Binquet C; Quantin C
    Cancer Epidemiol; 2015 Jun; 39(3):447-55. PubMed ID: 25819431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-Markov Arnason-Schwarz models.
    King R; Langrock R
    Biometrics; 2016 Jun; 72(2):619-28. PubMed ID: 26584064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer.
    Meier-Hirmer C; Schumacher M
    BMC Med Res Methodol; 2013 Jun; 13():80. PubMed ID: 23786493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferior vena cava filter placement and risk of hematogenous distant metastasis in ovarian cancer.
    Matsuo K; Carter CM; Ahn EH; Prather CP; Eno ML; Im DD; Rosenshein NB
    Am J Clin Oncol; 2013 Aug; 36(4):362-7. PubMed ID: 22643565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving efficiency in clinical trials using auxiliary information: Application of a multi-state cure model.
    Conlon AS; Taylor JM; Sargent DJ
    Biometrics; 2015 Jun; 71(2):460-8. PubMed ID: 25585942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic comparison of recurrent event models for application to composite endpoints.
    Ozga AK; Kieser M; Rauch G
    BMC Med Res Methodol; 2018 Jan; 18(1):2. PubMed ID: 29301487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint modeling of progression-free survival and death in advanced cancer clinical trials.
    Dejardin D; Lesaffre E; Verbeke G
    Stat Med; 2010 Jul; 29(16):1724-34. PubMed ID: 20572123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-homogeneous Markov processes for biomedical data analysis.
    Ocaña-Riola R
    Biom J; 2005 Jun; 47(3):369-76. PubMed ID: 16053260
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.